Class 4 Caution in Use
The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd WDA(H) 49276, who purchased from a company that does not hold a wholesale dealers authorisation and then sold it on to a number of other wholesalers.
Please visit the: MHRA website for more details on this drug alert.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batch |
---|---|---|---|
6839229 | Pi Eliquis Tabs 2.5mg 60 | Drugsrus Ltd | ABF5980 ABF6042 ABG1454 ABG1455 ABG1774 ABG1777 ABH0620 ABH0984 ABH4133 ABH4337 ABH4340 ABJ8246 ABJ8737 |
Alliance have not supplied | Eliquis 5 mg film-coated tablets | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Entyvio 300 mg powder for concentrate for solution for infusion | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Flutiform 250 microgram/10 microgram per actuation pressurised inhalation, suspension | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Privigen 20 g - 100 mg/ml solution for infusion | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Seretide Evohaler 25 microgram/125 microgram per metered dose pressurised inhalation, suspension | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Seretide Evohaler 25 microgram/250 microgram per metered dose pressurised inhalation, suspension | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Stelara 45 mg solution for injection in pre-filled syringe | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Stelara 90 mg solution for injection in pre-filled syringe | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Stelara 130 mg concentrate for solution for infusion | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Symbicort® Turbohaler® 200 micrograms/6micrograms inhalation, inhalation powder | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Synagis 100 mg/1 ml solution for injection | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Tysabri 300 mg concentrate for solution for infusion | Please refer to attached document | Please refer to attached document |
Alliance have not supplied | Zebinix 800mg tablets | Please refer to attached document | Please refer to attached document |
We will only be accepting Stock returns on PIP 6839229 Pi Eliquis Tabs 2.5mg 60 we are only able to accept stock back that is inactive or stolen stock.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Company contacts for further information Smartway Pharmaceuticals Limited • Email: regulatory@smartwaypharma.co.uk • Telephone: 020 8545 7743 Drugsrus Limited • Email: recall@drugsrus.co.uk • Telephone: 020 3397 2347 Optimal Pharma Limited • Email: info@optimalpharma.co.uk • Telephone: 020 3884 0032
If you have any questions, then please contact your local Service Centre Customer Services team.